Identification of a Novel Glucocorticoid Receptor Mutation in Budesonide-Resistant Human Bronchial Epithelial Cells

Molecular Endocrinology

Volumn 17, Issue 12, 2003, Pages 2566-2582

  Kunz, Susan ^a   Sandoval, Robert ^a   Carlsson, Peter ^c   Carlstedt Duke, Jan ^d   Bloom, John W ^a,b   Miesfeld, Roger L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c Karo Bio   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; GANCICLOVIR; GLUCOCORTICOID INTERACTING PROTEIN 1; GLUCOCORTICOID RECEPTOR; GLUTATHIONE TRANSFERASE; GREEN FLUORESCENT PROTEIN; MESYLIC ACID ETHYL ESTER; METHIONINE; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN; PROTEIN KINASE P60; STEROID; THYMIDINE KINASE; UNCLASSIFIED DRUG; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; BRONCHUS; CELL CLONE; CELL CULTURE; CELL LINE; CELL TYPE; CONTROLLED STUDY; ENZYME ASSAY; EPITHELIUM CELL; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC SELECTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; HORMONE BINDING; HORMONE RESPONSIVE ELEMENT; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; LUNG CARCINOMA; MALE; MOLECULAR DYNAMICS; MOLECULAR GENETICS; MOLECULAR MODEL; MUTANT; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN MOTIF; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SIMULATION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; BINDING SITES; BRONCHI; BUDESONIDE; CARCINOMA, BRONCHOGENIC; CELL LINE; CELL LINE, TUMOR; DRUG RESISTANCE; GANCICLOVIR; GLUTATHIONE TRANSFERASE; HUMANS; LUNG NEOPLASMS; METHIONINE; MOLECULAR SEQUENCE DATA; MUCOUS MEMBRANE; MUTATION, MISSENSE; RECEPTORS, GLUCOCORTICOID; RECOMBINANT FUSION PROTEINS; RESPIRATORY MUCOSA; TRANSFECTION; VALINE;

BRONCHUS; SIMPLEXVIRUS;

EID: 0347480262     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0164     Document Type: Article

References (67)

1. Szefler SJ 2001 A review of budesonide inhalation suspension in the treatment of pediatric asthma. Pharmacotherapy 21:195-206
2. Brattsand R 1999 The ideal steroid. Pulm Pharmacol Ther 12:119-122
3. Crim C, Pierre LN, Daley-Yates PT 2001 A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate. Clin Ther 23: 1339-1354
4. Skoner DP 2002 Growth effects of asthma and asthma therapy. Curr Opin Pulm Med 8:45-49
5. Lipworth BJ, Jackson CM 2000 Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf 23:11-33
6. Leung DY, Spahn JD, Szefler SJ 1999 Immunologic basis and management of steroid-resistant asthma. Allergy Asthma Proc 20:9-14
7. Barnes PJ 1991 Biochemistry of asthma. Trends Biochem Sci 16:365-369
8. Korn SH, Jerre A, Brattsand R 2001 Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J 17: 1070-1077
9. Smith PJ, Cousins DJ, Jee YK, Staynov DZ, Lee TH, Lavender P 2001 Suppression of granulocyte-macrophage colony-stimulating factor expression by glucocorticoids involves inhibition of enhancer function by the glucocorticoid receptor binding to composite NF-AT/ activator protein-1 elements. J Immunol 167:2502-2510
10. Lamas AM, Leon OG, Schleimer RP 1991 Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J Immunol 147: 254-259
11. Kwon OJ, Jose PJ, Robbins RA, Schall TJ, Williams TJ, Barnes PJ 1995 Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol 12:488-496
12. Spahn JD, Landwehr LP, Nimmagadda S, Surs W, Leung DY, Szefler SJ 1996 Effects of glucocorticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma. J Allergy Clin Immunol 98: 1073-1079
13. Schleimer RP, Bochner BS 1994 The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 94:1202-1213
14. Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG, Evans RM 1985 Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318:635-641
15. Oakley RH, Sar M, Cidlowski JA 1996 The human glucocorticoid receptor β isoform. Expression, biochemical properties, and putative function. J Biol Chem 271: 9550-9559
16. Ray DW, Davis JR, White A, Clark AJ 1996 Glucocorticoid receptor structure and function in glucocorticoidresistant small cell lung carcinoma cells. Cancer Res 56:3276-3280
17. Rivers C, Levy A, Hancock J, Lightman S, Norman M 1999 Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J Clin Endocrinol Metab 84:4283-4286
18. Beger C, Gerdes K, Lauten M, Tissing WJ, Fernandez-Munoz I, Schrappe M, Welte K 2003 Expression and structural analysis of glucocorticoid receptor isoform γ in human leukaemia cells using an isoform-specific realtime polymerase chain reaction approach. Br J Haematol 122:245-252
19. Galigniana MD, Radanyi C, Renoir JM, Housley PR, Pratt WB 2001 Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus. J Biol Chem 276: 14884-14889
20. Bourgeois S, Gruol DJ, Newby RF, Rajah FM 1993 Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis. Mol Endocrinol 7:840-851
21. Kralli A, Bohen SP, Yamamoto KR 1995 LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. Proc Natl Acad Sci USA 92:4701-4705
22. Miesfeld R, Bloom J 1997 Glucocorticoid receptor structure and function. In: Schleimer RP, Busse WW, P.M. OB, eds. Inhaled glucocorticoids in asthma. New York: Marcel Dekker, Inc.; 3-27
23. Jenkins BD, Pullen CB, Darimont BD 2001 Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol Metab 12:122-126
24. Krstic MD, Rogatsky I, Yamamoto KR, Garabedian MJ 1997 Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol 17:3947-3954
25. Rogatsky I, Logan SK, Garabedian MJ 1998 Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc Natl Acad Sci USA 95:2050-2055
26. Leung DY, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, Chrousos GP, Klemm DJ 1997 Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J Exp Med 186:1567-1574
27. Hamid QA, Wenzel SE, Hauk PJ, Tsicopoulos A, Wallaert B, Lafitte JJ, Chrousos GP, Szefler SJ, Leung DY 1999 Increased glucocorticoid receptor β in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 159:1600-1604
28. Webster JC, Oakley RH, Jewell CM, Cidlowski JA 2001 Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance. Proc Natl Acad Sci USA 98:6865-6870
29. Sousa AR, Lane SJ, Cidlowski JA, Staynov DZ, Lee TH 2000 Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor β-isoform. J Allergy Clin Immunol 105:943-950
30. Denny WB, Valentine DL, Reynolds PD, Smith DF, Scammell JG 2000 Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology 141:4107-4113
31. Harmon JM, Elsasser MS, Eisen LP, Urda LA, Ashraf J, Thompson EB 1989 Glucocorticoid receptor expression in receptorless mutants Isolated from the human leukemic cell line CEM-C7. Mol Endocrinol 3:734-743
32. Askew DJ, Kuscuoglu U, Brunner T, Green DR, Miesfeld RL 1999 Characterization of Apt-cell lines exhibiting cross-resistance to glucocorticoid-and Fas-mediated apoptosis. Cell Death Differ 6:796-804
33. Sitcheran R, Emter R, Kralli A, Yamamoto KR 2000 A genetic analysis of glucocorticoid receptor signaling. Identification and characterization of ligand-effect modulators in Saccharomyces cerevisiae. Genetics 156: 963-972
34. Chauhan S, Leach CH, Kunz S, Bloom JW, Miesfeld RL 2003 Glucocorticoid regulation of human eosinophil gene expression. J Steroid Biochem Mol Biol 84: 441-452
35. Loke TK, Sousa AR, Corrigan CJ, Lee TH 2002 Glucocorticoid-resistant asthma. Curr Allergy Asthma Rep 2:144-150
36. Bray PJ, Cotton RG 2003 Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum Mutat 21: 557-568
37. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, Craig TJ, Dolovich M, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kiley J, Kraft M, Lazarus SC, Lemanske Jr RF, Mauger E, Peters SP, Sorkness CA, and the Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute 2002 Significant variability in response to Inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 109:410-418
38. Bantel H, Schmitz ML, Raible A, Gregor M, Schulze-Osthoff K 2002 Critical role of NF-κB and stress-activated protein kinases in steroid unresponsiveness. FASEB J 16:1832-1834
39. Huizenga NA, de Lange P, Koper JW, de Herder WW, Abs R, Kasteren JH, de Jong FH, Lamberts SW 2000 Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene. J Clin Endocrinol Metab 85: 2076-2081
40. Volovitz B, Bentur L, Finkelsteln Y, Mansour Y, Shalitin S, Nussinovitch M, Varsano I 1998 Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks In children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol 102:605-609
41. Brattsand R, Thalen A, Roempke K, Kallstrom L, Gruvstad E 1982 Development of new glucocorticosteroids with a very high ratio between topical and systemic activities. Eur J Respir Dis Suppl 122:62-73
42. Tashjian Jr AH, Weintraub BD, Barowsky NJ, Rabson AS, Rosen SW 1973 Subunits of human chorionic gonadotropin: unbalanced synthesis and secretion by clonal cell strains derived from a bronchogenic carcinoma. Proc Natl Acad Sci USA 70:1419-1422
43. Dahiya R, Kwak KS, Byrd JC, Ho S, Yoon WH, Kim YS 1993 Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene. Cancer Res 53:1437-1443
44. Tiberghien P, Reynolds CW, Keller J, Spence S, Deschaseaux M, Certoux JM, Contassot E, Murphy WJ, Lyons R, Chiang Y 1994 Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation? Blood 84: 1333-1341
45. Hsu SC, Qi M, DeFranco DB 1992 Cell cycle regulation of glucocorticoid receptor function. EMBO J 11:3457-3468
46. Whitacre DC, Chuahan S, Davis T, Gordon D, Cress AE, Miesfeld R 2002 Androgen-induction of in vitro prostate cell differentiation. Cell Growth Differ 13:1-11
47. Xiao W, Oefner PJ 2001 Denaturing high-performance liquid chromatography: a review. Hum Mutat 17:439-474
48. Umesono K, Murakami KK, Thompson CC, Evans RM 1991 Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65:1255-1266
49. Miesfeld RL 2000 Glucocorticoid action: biochemistry. In: DeGroot LJ, Jameson JL, eds. Endocrinology. Philadelphia: WB Saunders Co.; 1647-1654
50. Vottero A, Kino T, Combe H, Lecomte P, Chrousos GP 2002 A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators. J Clin Endocrlnol Metab 87:2658-2667
51. Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM, Lambert MH, Moore JT, Pearce KH, Xu HE 2002 Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110:93-105
52. Kauppi B, Jakob C, Farnegardh M, Yang J, Ahola H, Alarcon M, Calles K, Engstrom O, Harlan J, Muchmore S, Ramqvist AK, Thorell S, Ohman L, Greer J, Gustafsson JA, Carlstedt-Duke J, Carlquist M 2003 The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J Biol Chem 278:22748-22754
53. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95:927-937
54. Mak HY, Hoare S, Henttu PM, Parker MG 1999 Molecular determinants of the estrogen receptor-coactivator interface. Mol Cell Biol 19:3895-3903
55. Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV 1998 Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395:137-143
56. Feng W, Ribeiro RC, Wagner RL, Nguyen H, Apriletti JW, Fletterick RJ, Baxter JD, Kushner PJ, West BL 1998 Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280:1747-1749
57. Williams SP, Sigler PB 1998 Atomic structure of progesterone complexed with its receptor. Nature 393:392-396
58. Pike AC, Brzozowski AM, Hubbard RE 2000 A structural biologist's view of the oestrogen receptor. J Steroid Biochem Mol Biol 74:261-268
59. Hong H, Darimont BD, Ma H, Yang L, Yamamoto KR, Stallcup MR 1999 An additional region of coactivator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors. J Biol Chem 274:3496-3502
60. Vanderbilt JN, Miesfeld R, Maler BA, Yamamoto KR 1987 Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol 1:68-74
61. Rogatsky I, Luecke HF, Leitman DC, Yamamoto KR 2002 Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc Natl Acad Sci USA 99: 16701-16706
62. Chapman MS, Askew DJ, Kuscuoglu U, Miesfeld RL 1996 Transcriptional control of steroid-regulated apoptosis in murine thymoma cells. Mol Endocrinol 10:967-978
63. Hollenberg SM, Giguere V, Segui P, Evans RM 1987 Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 49:39-46
64. Guex N, Peitsch MC 1997 SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714-2723
65. Appel RD, Bairoch A, Hochstrasser DF 1994 A new generation of information retrieval tools for biologists: the example of the ExPASy WWW server. Trends Biochem Sci 19:258-260
66. Bower MJ, Cohen FE, Dunbrack Jr RL 1997 Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool. J Mol Biol 267:1268-1282
67. Aqvist J, Marelius J 2001 The linear interaction energy method for predicting ligand binding free energies. Comb Chem High Throughput Screen 4:613-626